SAN FRANCISCO, July 17, 2025 /PRNewswire/ — Vehere, a leading provider of AI-powered Cyber Network Intelligence, has officially rolled out its latest NDR firmware v1.8.1 that introduces a modern, intuitive user interface, delivering greater operational efficiency for security teams. Designed for mission-critical environments, it reflects Vehere’s core philosophy: empower defenders with tools that reduce complexity… Continue reading Vehere Announces v1.8.1 Delivering Sharper Detection, Faster Response, and Smarter Workflows for Security Analysts
Category: Newswire
Customers Can Now Take Advantage of Various Transmission-Related Services in Rio Grande, Puerto Rico
RIO GRANDE, Puerto Rico, July 17, 2025 /PRNewswire/ — Flagship Mazda offers a range of transmission-related services for customers in Puerto Rico. Drivers in Rio Grande, Puerto Rico, now have a trusted destination for transmission care, as Flagship Mazda proudly announces the availability of a full suite of transmission-related services. From minor fluid changes to… Continue reading Customers Can Now Take Advantage of Various Transmission-Related Services in Rio Grande, Puerto Rico
Haier TV Has Been Awarded the EU Accessibility Act Certificate by DEKRA — Marking the First Certificate of its Kind in the TV Industry
QINGDAO, China, July 17, 2025 /PRNewswire/ — Haier, a world’s leading household appliances brand, announced that it has obtained the TV industry’s first European Accessibility Act (EAA) certificate for its LED TVs. This prestigious certification, awarded to Haier following a rigorous evaluation by DEKRA, encompasses a wide range of Haier’s smart LED TV products, including… Continue reading Haier TV Has Been Awarded the EU Accessibility Act Certificate by DEKRA — Marking the First Certificate of its Kind in the TV Industry
Guidehouse Research Estimates Global Market for Megawatt Charging Systems Will Reach Nearly $19 Billion by 2033
Market drivers include emissions reduction, government incentives, and cost BOULDER, Colo., July 17, 2025 /PRNewswire/ — A new report from Guidehouse Research evaluates the market for Megawatt Charging Systems (MCS) globally. Efforts to electrify medium- and heavy-duty vehicles (MHDVs) have focused on those with predictable routes and enough downtime to return to a depot for charging.… Continue reading Guidehouse Research Estimates Global Market for Megawatt Charging Systems Will Reach Nearly $19 Billion by 2033
SCU Brings Nation-Leading Chiropractic Program to Phoenix–A First for the Region
WHITTIER, Calif., July 17, 2025 /PRNewswire/ — Southern California University of Health Sciences (SCU) announced the expansion of its flagship Doctor of Chiropractic program to its Phoenix satellite campus, marking an historic first for the Southwestern U.S. region. With no other chiropractic programs currently operating in Arizona, New Mexico, Colorado, Wyoming, Idaho, Utah, or Nevada,… Continue reading SCU Brings Nation-Leading Chiropractic Program to Phoenix–A First for the Region
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ — A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when… Continue reading Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
Une étude de pharmacovigilance menée sur cinq ans par NTC confirme la sécurité des collyres à dose fixe pour la chirurgie de la cataracte
MILAN, 17 juillet 2025 /PRNewswire/ — Une étude de pharmacovigilance sur cinq ans récemment publiée confirme l’excellent profil de sécurité d’un collyre combiné à dose fixe contenant un stéroïde anti-inflammatoire et un antibiotique quinolone , développé par NTC, indiqué pour la prévention et le traitement de l’inflammation et la prévention de l’infection à la suite… Continue reading Une étude de pharmacovigilance menée sur cinq ans par NTC confirme la sécurité des collyres à dose fixe pour la chirurgie de la cataracte
Un estudio de NTC confirma la seguridad del colirio de combinación fija para la cirugía siguiente la catarata
Un estudio de farmacovigilancia de cinco años realizado por parte de NTC confirma la seguridad del colirio de combinación fija para la cirugía siguiente la catarata MILÁN, 17 de julio de 2025 /PRNewswire/ — Un estudio de farmacovigilancia de cinco años publicado recientemente confirma el excelente perfil de seguridad de un colirio de combinación fija que… Continue reading Un estudio de NTC confirma la seguridad del colirio de combinación fija para la cirugía siguiente la catarata
Fünfjährige Pharmakovigilanz-Studie von NTC bestätigt Sicherheit von fest dosierten Augentropfen nach Kataraktoperationen
MAILAND, 17. Juli 2025 /PRNewswire/ — Eine kürzlich veröffentlichte Fünf-Jahres-Pharmakovigilanzstudie bestätigt das ausgezeichnete Sicherheitsprofil eines von NTC entwickelten fest dosierten Kombinations-Augentropfens, der ein entzündungshemmendes Steroid und ein Chinolon-Antibiotikum enthält und zur Vorbeugung und Behandlung von Entzündungen und zur Vermeidung von Infektionen nach Kataraktoperationen bei Erwachsenen angezeigt ist. Die Studie wurde vorgelegt, als fast 4 Millionen Patienten… Continue reading Fünfjährige Pharmakovigilanz-Studie von NTC bestätigt Sicherheit von fest dosierten Augentropfen nach Kataraktoperationen
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ — A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when… Continue reading Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery